Skip to main content
. 2021 Jan 29;10(3):e018510. doi: 10.1161/JAHA.120.018510

Table 2.

COVID‐19 Experiences Among 587 Patients With Hypertension From 36 FQHC Clinics in Louisiana and Mississippi

Characteristic Tested Positive For COVID‐19, N (%) Exposure to Someone With Confirmed COVID‐19, N (%) Family or Friend With COVID‐19, N (%) Loss of Family or Friend Due to COVID‐19, N (%) Laid Off or Furloughed Due to COVID‐19, N (%) Required to Working at High Risk Job For COVID‐19 infection, N (%) Loss of Health Insurance During COVID‐19, N (%) Shortages of Food During COVID‐19, N (%) Loneliness Due to Quarantine, N (%)
Overall 16 (2.7) 43 (7.3) 147 (25.1) 90 (15.3) 85 (14.5) 85 (14.5) 17 (2.9) 93 (15.9) 154 (26.5)
Sex
Female 12 (3.4) 31 (8.9) 89 (25.5) 65 (18.6) 54 (15.4) 46 (13.1) 9 (2.6) 63 (18.0) 102 (29.5)
Male 4 (1.7) 12 (5.1) 57 (24.2) 25 (10.6) 31 (13.1) 39 (16.5) 8 (3.4) 29 (12.3) 52 (22.2)
Race
Black 15 (3.9)* 37 (9.7) 111 (29.2) 74 (19.4) 61 (16.0) 59 (15.5) 11 (2.9) 65 (17.1) 98 (26.1)
Non‐Black 1 (0.5)* 6 (2.9) 36 (17.5) 16 (7.8) 24 (11.7) 26 (12.6) 6 (2.9) 28 (13.6) 56 (27.2)
Age
≥65 y 3 (1.9) 9 (5.8) 32 (20.6) 24 (15.5) 10 (6.5) 9 (5.8) 2 (1.3) 9 (5.8) 36 (23.5)
<65 y 13 (3.0) 34 (7.9) 115 (26.7) 66 (15.3) 75 (17.4) 76 (17.6) 15 (3.5) 84 (19.5) 118 (27.6)
High school education or higher
Yes 12 (2.7) 36 (8.0) 122 (27.1)* 79 (17.5) 72 (15.9) 76 (16.8) 15 (3.3) 73 (16.2) 115 (25.7)
No 4 (3.0) 7 (5.2) 25 (18.7)* 11 (8.2) 13 (9.7) 9 (6.7) 2 (1.5) 20 (14.9) 38 (28.8)
Type of insurance
Public 13 (3.1) 28 (6.6) 108 (25.6) 66 (15.6) 55 (13.0) 42 (10.0) 10 (2.4) 70 (16.6) 124 (29.6)*
Private 1 (1.3) 10 (12.8) 19 (24.7) 9 (11.5) 12 (15.4) 26 (33.3) 3 (3.8) 6 (7.7) 14 (18.4)*
Uninsured 2 (2.3) 5 (5.8) 20 (23.3) 15 (17.4) 18 (20.9) 17 (19.8) 4 (4.7) 17 (19.8) 16 (18.8)*
Employment
Employed 7 (3.2) 25 (11.6) 63 (29.3) 41 (19.0)* 67 (31.0) 78 (36.1) 13 (6.0) 39 (18.1) 53 (24.7)
Retired 5 (2.4) 11 (5.2) 51 (24.2) 31 (14.7)* 7 (3.3) 0 (0.0) 2 (0.9) 24 (11.4) 62 (29.8)
Unemployed 4 (2.7) 6 (4.1) 28 (18.9) 14 (9.5)* 10 (6.8) 7 (4.7) 2 (1.4) 28 (19.0) 36 (24.7)
Body mass index, kg/m2
<25 0 (0.0) 2 (3.4) 16 (27.6) 11 (19.0) 8 (13.8) 10 (17.2) 0 (0.0) 11 (19.0) 17 (29.8)
25‐29.9 3 (2.3) 7 (5.3) 32 (24.4) 22 (16.8) 16 (12.2) 17 (13.0) 6 (4.6) 18 (13.7) 36 (28.1)
≥30 13 (3.4) 33 (8.6) 97 (25.3) 55 (14.3) 59 (15.3) 57 (14.8) 11 (2.9) 63 (16.4) 99 (25.8)
Number of comorbidities §
0 5 (3.7) 13 (9.6) 32 (23.7) 20 (14.7) 27 (19.9) 30 (22.1) 10 (7.4) 22 (16.2) 34 (25.0)
1 3 (1.4) 10 (4.7) 47 (22.3) 26 (12.3) 24 (11.4) 29 (13.7) 3 (1.4) 32 (15.2) 54 (26.1)
2+ 8 (3.5) 19 (8.3) 62 (27.1) 39 (17.0) 30 (13.1) 22 (9.6) 4 (1.7) 36 (15.7) 61 (26.9)

COVID‐19, coronavirus disease 2019; and FQHC, federally qualified health center.

*

P<0.05,

P<0.01,

P<0.0001.

§

Comorbidities include diabetes mellitus, high cholesterol, history of stroke, myocardial infarction, heart failure, and chronic kidney disease in addition to hypertension.